Individualizing gentamicin dosage in patients with cystic fibrosis: Limitations to pharmacokinetic approach
- 1 February 1987
- journal article
- research article
- Published by Elsevier in The Journal of Pediatrics
- Vol. 110 (2) , 303-310
- https://doi.org/10.1016/s0022-3476(87)80178-6
Abstract
No abstract availableThis publication has 18 references indexed in Scilit:
- Identification of children for whom routine monitoring of aminoglycoside serum concentrations is not cost effectiveThe Journal of Pediatrics, 1986
- Individualization of tobramycin dosage in patients with cystic fibrosisThe Pediatric Infectious Disease Journal, 1984
- Disposition of tobramycin in patients with cystic fibrosis: A prospective controlled studyThe Journal of Pediatrics, 1984
- Pharmacokinetics of tobramycin in cystic fibrosisThe Journal of Pediatrics, 1982
- Dosing implications of altered gentamicin disposition in patients with cystic fibrosisThe Journal of Pediatrics, 1982
- A Model for Dosing Gentamicin in Children and Adolescents that Adjusts for Tissue Accumulation with Continuous Dosing1Clinical Pharmacokinetics, 1980
- Gentamicin disposition and tissue accumulation on multiple dosingJournal of Pharmacokinetics and Biopharmaceutics, 1977
- Tobramycin Therapy of Infections Due to Pseudomonas aeruginosa in Patients with Cystic Fibrosis: Effect of Dosage and Concentration of Antibiotic in SputumThe Journal of Infectious Diseases, 1976
- Pharmacokinetics of dosing regimens which utilize multiple intravenous infusions: Gentamicin in burn patientsJournal of Pharmacokinetics and Biopharmaceutics, 1976
- Carbenicillin and gentamicin: Pharmacologic studies in patients with cystic fibrosis and pseudomonas pulmonary infectionsThe Journal of Pediatrics, 1971